UTime Signs NDA to Acquire Monkeypox Vaccine Maker Bowen Therapeutics Inc and Supports Completion of FDA Registration of Related Vaccines
UTime Limited - Ordinary Shares (WTO)
Company Research
Source: PR Newswire
Impact Snapshot
Event Time:
WTO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WTO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WTO alerts
High impacting UTime Limited - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
WTO
News
- UTime Limited Received Nasdaq Notification Letter Regarding Bid Price DeficiencyGlobeNewswire
- UTime Limited Announces Pricing of $5 Million Registered Direct OfferingGlobeNewswire
- UTime Limited Announces 1-For-25 Reverse Share SplitGlobeNewswire
- UTime Initiates Financial and Legal Due Diligence on Bowen TherapeuticsPR Newswire
- UTime Initiates Financial and Legal Due Diligence on Bowen TherapeuticsPR Newswire